Introduction
Allergy, infections, asthma, allergies, Infection, eczema
ALLERGY, INFECTIONS, ASTHMA, ALLERGIES, INFECTION, ECZEMA
The Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR) is an ongoing, multicentre randomised controlled trial (RCT) to determine the off-target effects of neonatal BCG vaccination on allergies, eczema, infections and asthma in Australian infants.